Viralytics

focuses on the development of oncolytic immunotherapies for the treatment of cancer...
Read more
Viralytics CEO: Malcolm McColl

CEO

Malcolm McColl

CEO Approval Rating

73/100

Annual Revenue
$ < 1M
Employees
3
Funding
$65M

Viralytics Competitors

1Genelux
2ViraTherapeutics
3DNAtrix
4Virttu
5Oncorus
6bluebird bio
7Kite Pharma
8Candel Therapeutics
9CG Oncology
10Spark Therapeutics

Trending Companies